Home > National Drug Code (NDC) > NovoLog Mix 70/30

NovoLog Mix 70/30 - 0169-3696-19 - (insulin aspart)

Alphabetical Index


Drug Information of NovoLog Mix 70/30

Product NDC: 0169-3696
Proprietary Name: NovoLog Mix 70/30
Non Proprietary Name: insulin aspart
Active Ingredient(s): 100    [iU]/mL & nbsp;   insulin aspart
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of NovoLog Mix 70/30

Product NDC: 0169-3696
Labeler Name: Novo Nordisk
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021172
Marketing Category: NDA
Start Marketing Date: 20020911

Package Information of NovoLog Mix 70/30

Package NDC: 0169-3696-19
Package Description: 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) > 3 mL in 1 SYRINGE, PLASTIC

NDC Information of NovoLog Mix 70/30

NDC Code 0169-3696-19
Proprietary Name NovoLog Mix 70/30
Package Description 5 SYRINGE, PLASTIC in 1 CARTON (0169-3696-19) > 3 mL in 1 SYRINGE, PLASTIC
Product NDC 0169-3696
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name insulin aspart
Dosage Form Name INJECTION, SUSPENSION
Route Name SUBCUTANEOUS
Start Marketing Date 20020911
Marketing Category Name NDA
Labeler Name Novo Nordisk
Substance Name INSULIN ASPART
Strength Number 100
Strength Unit [iU]/mL
Pharmaceutical Classes Insulin [Chemical/Ingredient],Insulin Analog [EPC]

Complete Information of NovoLog Mix 70/30


General Information